Milestone Scientific (MLSS) Competitors $1.08 +0.16 (+17.39%) Closing price 03:59 PM EasternExtended Trading$1.04 -0.04 (-4.07%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock MLSS vs. NNOX, STIM, SMTI, ZIMV, RCEL, SNWV, NVRO, NYXH, ELMD, and PDEXShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), SANUWAVE Health (SNWV), Nevro (NVRO), Nyxoah (NYXH), Electromed (ELMD), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Nano-X Imaging Neuronetics Sanara MedTech ZimVie AVITA Medical SANUWAVE Health Nevro Nyxoah Electromed Pro-Dex Nano-X Imaging (NASDAQ:NNOX) and Milestone Scientific (NYSE:MLSS) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation. Is NNOX or MLSS more profitable? Milestone Scientific has a net margin of -52.01% compared to Nano-X Imaging's net margin of -465.38%. Nano-X Imaging's return on equity of -27.63% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-465.38% -27.63% -24.72% Milestone Scientific -52.01%-60.26%-40.23% Which has more volatility and risk, NNOX or MLSS? Nano-X Imaging has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Do analysts rate NNOX or MLSS? Nano-X Imaging currently has a consensus price target of $12.00, suggesting a potential upside of 137.39%. Milestone Scientific has a consensus price target of $1.25, suggesting a potential upside of 32.70%. Given Nano-X Imaging's higher probable upside, equities research analysts clearly believe Nano-X Imaging is more favorable than Milestone Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer NNOX or MLSS? Nano-X Imaging received 32 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 73.91% of users gave Nano-X Imaging an outperform vote while only 2.25% of users gave Milestone Scientific an outperform vote. CompanyUnderperformOutperformNano-X ImagingOutperform Votes3473.91% Underperform Votes1226.09% Milestone ScientificOutperform Votes22.25%Underperform Votes8797.75% Do insiders and institutionals hold more shares of NNOX or MLSS? 21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by company insiders. Comparatively, 24.8% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, NNOX or MLSS? Milestone Scientific has lower revenue, but higher earnings than Nano-X Imaging. Milestone Scientific is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$11.28M25.89-$60.78M-$0.90-5.62Milestone Scientific$8.63M8.56-$6.93M-$0.07-13.46 Does the media favor NNOX or MLSS? In the previous week, Nano-X Imaging and Nano-X Imaging both had 1 articles in the media. Nano-X Imaging's average media sentiment score of 1.87 beat Milestone Scientific's score of 0.59 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Overall Sentiment Nano-X Imaging Very Positive Milestone Scientific Positive SummaryNano-X Imaging beats Milestone Scientific on 12 of the 16 factors compared between the two stocks. Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$73.83M$9.21B$5.50B$18.97BDividend YieldN/A1.64%5.11%4.02%P/E Ratio-13.4619.3522.6332.98Price / Sales8.5670.92398.0928.04Price / CashN/A19.6738.1817.52Price / Book8.565.016.724.49Net Income-$6.93M$284.66M$3.22B$1.02B7 Day Performance-0.84%0.41%1.58%0.94%1 Month Performance-0.84%2.48%4.09%-2.42%1 Year Performance47.19%-16.54%16.05%4.78% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific0.8835 of 5 stars$1.08+17.4%$1.25+15.7%+48.4%$84.65M$8.63M-15.4330Gap UpHigh Trading VolumeNNOXNano-X Imaging2.5769 of 5 stars$4.75-8.7%$12.00+152.6%-43.9%$274.45M$11.28M-5.59190Positive NewsSTIMNeuronetics1.2716 of 5 stars$3.88+3.2%$5.50+41.8%+30.0%$255.36M$74.89M-3.15180Upcoming EarningsNews CoverageSMTISanara MedTech2.0281 of 5 stars$28.66-2.6%$48.50+69.2%+0.3%$255.13M$86.67M-28.9560News CoverageZIMVZimVie2.4918 of 5 stars$8.92-5.0%$19.50+118.6%-40.4%$248.40M$449.75M-0.682,700Positive NewsRCELAVITA Medical1.6922 of 5 stars$9.10-1.2%$17.25+89.6%+15.4%$240.56M$64.25M-3.81130Upcoming EarningsPositive NewsSNWVSANUWAVE HealthN/A$28.00-6.6%N/AN/A$239.37M$32.63M-7.1840NVRONevro0.1892 of 5 stars$5.85+0.1%$5.36-8.3%-44.7%$224.32M$408.52M-3.091,090Upcoming EarningsAnalyst ForecastNYXHNyxoah2.2865 of 5 stars$5.94-1.5%$14.50+144.1%-41.0%$202.32M$4.52M-3.18110ELMDElectromed0.6164 of 5 stars$22.62-0.7%$38.00+68.0%+32.4%$193.56M$59.63M30.16160Analyst UpgradePDEXPro-Dex1.4213 of 5 stars$58.31-4.1%$52.00-10.8%+255.0%$190.15M$61.00M29.01140Earnings ReportShort Interest ↑News Coverage Related Companies and Tools Related Companies Nano-X Imaging Alternatives Neuronetics Alternatives Sanara MedTech Alternatives ZimVie Alternatives AVITA Medical Alternatives SANUWAVE Health Alternatives Nevro Alternatives Nyxoah Alternatives Electromed Alternatives Pro-Dex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
